Quantifying the impact of delayed delivery of cardiac rehabilitation on patients' health.
Cardiac rehabilitation
completion
cost effectiveness
delay
economic evaluation
uptake
Journal
European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
28
3
2020
medline:
26
8
2021
entrez:
28
3
2020
Statut:
ppublish
Résumé
Despite its role as an effective intervention to improve the long-term health of patients with cardiovascular disease and existence of national guidelines on timeliness, many health services still fail to offer cardiac rehabilitation in a timely manner after referral. The impact of this failure on patient health and the additional burden on healthcare providers in an English setting is quantified in this article. Two logistic regressions are conducted, using the British Heart Foundation National Audit of Cardiac Rehabilitation dataset, to estimate the impact of delayed cardiac rehabilitation initiation on the level of uptake and completion. The results of these regressions are applied to a decision model to estimate the long-term implications of these factors on patient health and National Health Service expenditure. We demonstrate that the failure of 43.6% of patients in England to start cardiac rehabilitation within the recommended timeframe results in a 15.3% reduction in uptake, and 7.4% in completion. These combine to cause an average lifetime loss of 0.08 years of life expectancy per person. Scaled up to an annual cohort this implies 10,753 patients not taking up cardiac rehabilitation due to the delay, equating to a loss of 3936 years of life expectancy. We estimate that an additional £12.3 million of National Health Service funding could be invested to alleviate the current delay. The current delay in many patients starting cardiac rehabilitation is causing quantifiable and avoidable harm to their long-term health; policy and research must now look at both supply and demand solutions in tackling this issue.
Sections du résumé
BACKGROUND
Despite its role as an effective intervention to improve the long-term health of patients with cardiovascular disease and existence of national guidelines on timeliness, many health services still fail to offer cardiac rehabilitation in a timely manner after referral. The impact of this failure on patient health and the additional burden on healthcare providers in an English setting is quantified in this article.
METHODS
Two logistic regressions are conducted, using the British Heart Foundation National Audit of Cardiac Rehabilitation dataset, to estimate the impact of delayed cardiac rehabilitation initiation on the level of uptake and completion. The results of these regressions are applied to a decision model to estimate the long-term implications of these factors on patient health and National Health Service expenditure.
RESULTS
We demonstrate that the failure of 43.6% of patients in England to start cardiac rehabilitation within the recommended timeframe results in a 15.3% reduction in uptake, and 7.4% in completion. These combine to cause an average lifetime loss of 0.08 years of life expectancy per person. Scaled up to an annual cohort this implies 10,753 patients not taking up cardiac rehabilitation due to the delay, equating to a loss of 3936 years of life expectancy. We estimate that an additional £12.3 million of National Health Service funding could be invested to alleviate the current delay.
CONCLUSIONS
The current delay in many patients starting cardiac rehabilitation is causing quantifiable and avoidable harm to their long-term health; policy and research must now look at both supply and demand solutions in tackling this issue.
Identifiants
pubmed: 32212842
doi: 10.1177/2047487320912625
pmc: PMC7564289
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1775-1781Références
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
Can J Cardiol. 2011 Sep-Oct;27(5):619-27
pubmed: 21477969
Eur J Prev Cardiol. 2019 Nov;26(17):1816-1823
pubmed: 31067128
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):608-20
pubmed: 26555125
Eur J Prev Cardiol. 2018 Jan;25(1):19-28
pubmed: 29120237
Eur J Prev Cardiol. 2017 Sep;24(13):1351-1357
pubmed: 28633533
Eur J Prev Cardiol. 2014 Jun;21(6):664-81
pubmed: 22718797
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi
pubmed: 25692211
Circulation. 2013 Jan 22;127(3):349-55
pubmed: 23250992
J Cardiopulm Rehabil Prev. 2011 Nov-Dec;31(6):373-7
pubmed: 21826016
Open Heart. 2016 Feb 08;3(1):e000369
pubmed: 26870390